Cargando…
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation
Mesenchymal stromal cells (MSCs) have the potential to suppress pathological activation of immune cells and have therefore been considered for the treatment of Graft-versus-Host-Disease. The clinical application of MSCs requires a process validation to ensure consistent quality. A flow cytometry-bas...
Autores principales: | Piede, Natascha, Bremm, Melanie, Farken, Anne, Pfeffermann, Lisa-Marie, Cappel, Claudia, Bonig, Halvard, Fingerhut, Theres, Puth, Laura, Vogelsang, Kathrin, Peinelt, Andreas, Marschalek, Rolf, Müller, Matthias, Bader, Peter, Kuçi, Zyrafete, Kuçi, Selim, Huenecke, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047294/ https://www.ncbi.nlm.nih.gov/pubmed/36980191 http://dx.doi.org/10.3390/cells12060850 |
Ejemplares similares
-
A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on β-TCP Scaffold and Show Increased Ability for Osteogenic Differentiation
por: Leppik, Liudmila, et al.
Publicado: (2022) -
In vitro migration and proliferation (“wound healing”) potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2015) -
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
por: Bonig, Halvard, et al.
Publicado: (2023) -
Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells
por: Bremm, Melanie, et al.
Publicado: (2019) -
Molecular signature of human bone marrow-derived mesenchymal stromal cell subsets
por: Kuçi, Selim, et al.
Publicado: (2019)